Galectin-3, a biomarker of cardiac inflammation and fibrosis, is increased in patients who are obese, and elevated levels of galectin-3 along with higher BMI levels are linked to an increased risk of future HF [84]. This evidence concerns the gene LGALS3 and hydrops fetalis.